Vascular cognitive impairment (VCI) currently lacks effective pharmacological interventions, underscoring the need to identify novel therapeutic targets. Increasing evidence suggests that amyloid-β (Aβ) contributes to VCI pathogenesis by promoting neurovascu... ...

请注册登录后继续浏览